These newer therapies, including copyright , belong to a group of drugs called GLP-1 receptor agonists . Primarily intended for managing high blood sugar, they function by helping the organism to produce adequate insulin and curbing excessive sugar levels. Beyond diabetes, their ability to promote slimming has resulted to increased interest and bro